相关实验视频

Updated: Jan 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

降脂疗法与LDL-C,apoB和非HDL-C分布的差异之间的关联

Marcin Ziółkowski¹, Karolina Obońska², Jakub Ratajczak²

¹Antoni Jurasz University Hospital No. 1 in Bydgoszcz, 85-094 Bydgoszcz, Poland.

Journal of clinical medicine

|January 10, 2026

概括

降脂疗法 (LLT) 有助于调整胆固醇标记物,如低密度脂蛋白胆固醇 (LDL-C),非高密度脂蛋白胆固醇 (非HDL-C) 和阿波脂蛋白B (apoB). 联合LLT在减少这些关键超脂血症指标之间的差异方面最有效.

科学领域:

心脏病学心脏病学
临床化学临床化学
药物治疗药物治疗

背景情况:

高胆固醇血症的诊断依赖于实验室的脂质参数.
降脂疗法 (LLT) 对于管理高胆固醇至关重要.
了解治疗期间的标记物分布对于有效治疗至关重要.

研究的目的:

为了评估低密度脂蛋白胆固醇 (LDL-C),非高密度脂蛋白胆固醇 (非HDL-C) 和阿波利波蛋白B (apoB) 度的差异.
根据LLT的存在和类型来评估这些差异.
为了确定不同治疗方案下的高脂血症分类中的差异.

主要方法:

追溯分析5048名患者的脂质测量.
脂质分数与最近的ESC指南截止值相比.
基于单一与联合LLT (他,埃泽提米布) 的亚组分析.

主要成果:

在未接受治疗的患者中,LDL-C和apoB之间的不一致性发生在26.6%的未接受治疗的患者中,而在接受治疗的患者中,该比例为13.6%.
综合LLT显示不一致率较低 (例如,LDL-C/apoB为8.6%),而不是单个LLT.
非HDL-C和LDL-C差异也减少了LLT,特别是组合疗法.

结论:

超脂血症分类显示了LDL-C,非HDL-C和apoB之间的显著差异.
实际上,LLT有效地减少了这些标记差异.
联合LLT在调整脂质参数方面表现出卓越的有效性.

关键词:

在 ApoB ApoB 中.这就是为什么LDL,LDL是LDL.脱脂血症是什么脱脂血症降脂疗法是一种降脂疗法.其他非HDL-C.

更多相关视频

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...